LC-MS determination and pharmacokinetic study of salidroside in rat plasma after oral administration of suspensions of traditional Chinese medicine Erzhi Wan and Fructus Ligustri lucidi  by Li, Ze-Yun et al.
J Pharm Anal Vol 1, No I, 8 -12 (2011)
ORIGINAL ARTICLES
LC-MS determination and pharmacokinetic study of salidroside in
rat plasma after oral administration of suspensions of traditional
Chinese medicine Erzhi Wan and Fructus Ligustri lucidi
:ze.Yun Li, Qing Li, Jiang Lii, Jun-Hong Ling, Xi-Hua Yu, Xiao-Hui Chen, Kai-Shun Bi'
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Abstract: A simple, rapid and sensitive liquid chromatography-mass spectrometry (LC-MS) method was developed for the
determination of salidroside in rat plasma and study of its pharmacokinetics after oral administration of suspension of
Erzhi Wan and Fructus Ligustri lucidi into Wistar rats. Plasma sample of 200 p.L was extracted with acetic ether-
isopropanol (2 : 1) and the extraction was performed on a Kromasil CIS column (150 mm x 4. 6 mm, 5 p.m) with the
mobile phase of methanol-water (41: 59, v/v) within a run time of 6.0 min. The analyte was monitored with positive
electrospray ionization (ESI) by selected ion monitoring (SIM) mode. The target ions were m/z 323.05 for salidroside
and m/z 411.05 for internal standard (IS) geniposide. A good linear relationship was obtained over the range of 5.0-
500.0 ng/mL and the lower limit of quantification was 5.0 ng/mL. The validated method was successfully applied to the
pharmacokinetic study of salidroside in rat plasma after oral administration of suspension of Erzhi Wan and Fructus
Ligustri lucidi.
Keywords: liquid chromatography-mass spectrometry (LC-MS); pharmacokinetics; salidroside; Erzhi Wan; Fructus
Ligustri lucidi
1 Introduction
Erzhi Wan, listed in Chinese Pharmacopoeia (2010 Edi-
tion) [1], composed of Fructus Ligustri lucidi and Herba
Ecliptae, is a well-known traditional Chinese medicinal
(TCM) formulation, which was first recorded by Wang
Ang in his 1682 AD publication Yifang Jijie (Collection of
Medical Formulas) [2]. According to Wang Ang, Erzhi
Wan is a nourishing formula, which can "supplement the
lower back and knees, strengthen the sinews and bones,
strengthen the kidneys, and blacken hair" [2]. The pair of
herbs, Fructus Ligustri lucidi and Herba Ecliptae, as basic
composition units of TCM formulations, have special clini-
cal significance and are increasingly mentioned in modern
Chinese medical literature [3, 4]. It is reported that they
have some kinds of synergetic effects. Fructus Ligustri
lucidi, recorded in Chinese Pharmacopoeia (2010 Edition)
[1], has been used as traditional medicine for thousands of
years. Recent pharmacological studies have shown that
Fructus Ligustri lucidi has many strong activities, such as
anti- fatigue, anti-oxidant, anti-tumor, anti-aging, and
adaptogenic ones [5, 6]. Salidroside (Figure 1a) is one of
the active ingredients in Fructus Ligustri lucidi and Erzhi
Wan, with enhancing immunity, anti-aging and some other
important pharmacological effects [7,8]. Therefore, it is
significant to study the pharmacokinetics of salidroside in
Erzhi Wan and Fructus Ligustri lucidi for the clinical use
of them.
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Many analytical methods for the determination of sali-
droside in Rhodiola species have been reported and the
pharmacokinetics of pure salidroside in rat plasma has also
been studied [9-13]. However, there are few literature
reports on the determination of salidroside in Fructus
Ligustri lucidi. Besides, due to the interaction of TCM
ingredients, it is necessary to explore whether some other
ingredients in Fructus Ligustri lucidi or Herba Ecliptae
affect the pharmacokinetic behavior of salidroside. As far
as we know, there is no published report on the pharmaco-
kinetic studies of the compound in rat plasma after adminis-
tration of Erzhi Wan and Fructus Ligustrum lucidum. In
our study, a liquid chromatography-electrospray ionisation-
tandem mass spectrometry (LGESI-MS) method was de-
veloped and validated for the determination of salidroside in
rat plasma and for the pharmacokinetic study of the com-
pound after oral administration of Erzhi Wan and Fructus
Ligustrum lucidum.
2 Experimental
2.1 Materials, chemicals and reagents
Fructus Ligustri lucidi and Herba Ecliptae were purchased
from Tongrentang (Shenyang, China) and identified by
Professor Qi-Shi Sun (Department of Pharmacognosy,
Shenyang Pharmaceutical University, Shenyang, China).
Salidroside was purchased from the National Institute for
Control of Pharmaceutical and Biological Products (Bei-
jing, China). Geniposide (Figure 1b) was isolated from G.
jasminoides in our laboratory. Its structure was fully char-
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Figure 2 Full scan mass spectra of salidroside (a) and IS (b)
Erzhi Wan suspension was prepared as follows: about
100.0 g Fructus Ligustri lucidi was crushed to powder, and
then was sifted through a 100 mesh sieve. 30.0 g of Herba
Ecliptae was decocted twice, 1 h each time, with suitable
amounts of water. After that, the decoction was filtered
and concentrated. The concentrate was mixed with 30.0 g
fine powder and added with appropriate amounts of water
to 100 mL, giving a Ligustri lucidi concentration of 0.3 g!
mL (expressed as the weight of herbal material in water).
Shake well before use.
Fructus Ligustri lucidi suspension was prepared as fol-
lows: 30. 0 g of Fructus Ligustri lucidi powder (prepared
above) was suspended with appropriate amounts of water to
100 mL, giving a Ligustri lucidi concentration of 0.3 g!mL
(expressed as the weight of herbal material in water).
Shake well before use.
2.5 Preparation of plasma samples
The plasma (200 ILL) was spiked with 50 ILL of IS (40 ng!
mL), 50 ILL of methanol, and 1 mL of acetic ether-isopro-
panol (2 : 1). The mixture was vortex-mixed for 3 min,
Figure 1 Chemical structures of salidroside (a) and IS (b)
tion) [1]. Fructus Ligustri lucidi suspension was made to
have the same concentration of Fructus Ligustri lucidi as
Erzhi Wan suspension. The dosage form of suspension was
chosen for its convenience in gastric perfusion.
Erzhi Wan suspension was made according to preparation
of Erzhi Wan stated in Chinese Pharmacopoeia (2010 Edi-
2.3 LC-MS instruments and analytical conditions
The assay was performed on Shimadzu (Japan) LC-MS
2010A system. Liquid chromatographic separation was
achieved on a Kromasil Cs column (150 mm x 4. 6 mm,
5 ILm) and preceded by a CIS guard column (4.0 mm x 2.0
mm, Phenomenex, Torrance, CA, USA). The column and
autosampler tray temperature were kept constant at 25 'c
and 4 'C, respectively. The mobile phase was methanol-
water (41: 59, v/v). The flow rate was set atO.8mL1min
with 25% of the eluent split into the inlet of the mass spec-
trometer and the injection volume was set at 20 ILL. Time of
the analysis was 6 min.
The electrospray ionization (ESI) was performed using
nitrogen to assist nebulization (the flow rate was set at 1.5
U min ). The analytes were ionized by an ESI source in
positive ion mode under the following source conditions:
Nebulizing gas 1. 5 Umin; drying gas 2.0 Umin; COL
temperature 250 'C; heat block temperature 200 'C; detec-
tor voltage 1. 75 kV; the other parameters were fixed as for
the tuning file. Analysis was carried out in selected ion
monitoring at the [M + Na]+ , m/z 323.05 for salidroside
and [M + Na]+ m/z 411.05 for IS. The full-scan mass
spectra of salidroside and IS after injection in mobile phase
are shown in Figure 2.
2.4 Preparation of Eruu Wan s~ion and Fructus Ligu-
stri lucidi suspension
2.2 Animals
Male pathogen-free Wistar rats (220 - 270 g) were purchased
from the Experimental Animal Center of Shenyang Phar-
maceutical University. Animal experiments were carried out
in accordance with the Guidelines for Animal Experimenta-
tion of Shenyang Pharmaceutical University and the proto-
col was approved by the Animal Ethics Committee of this
institution. The rats were fed with a standard laboratory
diet and water for at least 3 days before the experiments.
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and then centrifuged at 15000 rpm for 3 min. The superna-
tant was transferred into a clean test tube and evaporated to
dryness in a thermostatic controller at 30'C under a slight
stream of nitrogen. The residue was reconstituted in 100 flL
mobile phase, with vortex mixing for 2 min, and repeatedly
centrifuged at 15000 rpm for 5 min. An aliquot of 20 flL
was injected into the LC-MS system for analysis.
2.6 Method validation
2.6.1 Selectivity
Selectivity was assessed by comparing chromatograms of six
different batches of blank rat plasma with those of corre-
sponding standard plasma samples spiked with salidroside, IS,
and a plasma sample obtained after drug administration.
2.6.2 Linearity and lower limit of quantification (LLOQ)
Calibration curves were prepared by assaying standard plas-
ma samples at six concentrations of salidroside ranging from
5.0 to 500.0 ngimL. The linearity was determined by plot-
ting the peak area ratio (y) of salidroside to IS versus the
nominal concentration (x) of salidroside. The calibration
curve was constructed by weighted (l/~) least squares
linear regression. The LLOQ was estimated in accordance
with the base line noise, considering a signal-to-noise ratio
of 10 : 1.
2.6.3 Precision and accuracy
The intra-day precision and accuracy were determined by
analyzing six QC replicates at concentrations of 10.0, 100.0
and 400.0 nglmL for salidroside on one day (n = 5), and
inter-day precision and accuracy by repeated analysis on
three consecutive days (n =5 series per day). Accuracy was
defined as the relative error (RE %) while the precision
was defined as the relative standard deviation (RSO %).
2.6.4 Extraction recovery
Recovery of the extraction procedure was evaluated at three
concentrations (10.0, 100.0 and 400.0 nglmL) for salidro-
side and at 40.0 nglmL for the IS. It was determined by
comparing the mean peak areas (n =6, at each concentra-
tion) obtained from plasma samples spiked before extrac-
tion with those from plasma samples spiked after extraction.
2.6.5 Stability
The stability of processing (3 freeze-thaw cycles),
sample storage (at room temperature for 4 h, at - 20'C for
7 d), and post-treatment (in the reconstituted extract at
4 'c kept from light and in the auto-sampler tray for 8 h)
was assessed by analyzing replicates (n = 3) of QC samples.
The resulting concentrations were compared with their the-
oretical concentrations, and the percentage of deviation was
calculated. Samples were to be concluded stable if the rela-
tive error was within ±15%.
2.6.6 Phannacokinetic application
Wistar rats were divided into two groups randomly (n =6)
and were fasted 12 h before dosing and with free access to
water during the experiment. The proposed method was
applied to the pharmacokinetic studies after oral adminis-
tration of 2 mL suspension of Erzhi Wan (group one) and
2 mL suspension of Ligustrum lucidum (group two). Blood
samples from the orbital veins of the rats (0. 5 mL) were
withdrawn into the heparinized tubes at 0 (before dosing),
O. 17, O. 33, O. 5, O. 75, 1, 1. 5, 2, 2. 5, 3, 5, 9, and 12 h
and immediately centrifuged at 15000 rpm for 5 min. The
plasma samples were stored at - 20'C until analysis. The
plasma concentrations of salidroside at different time points
are expressed as mean ± SO, and the mean concentration
versus time curve was plotted. All the data were calculated
by OAS 2.1 statistical software (Pharmacology Institute of
China) .
3 Results and discussion
3.1 Method validation
3.1.1 Specificity
No endogenous interference was observed at retention times
of salidroside (3.6 min) and IS (5.2 min) because of the
high selectivity of SIM mode. Typical chromatograms of
blank plasma, spiked plasma sample and subject sample are
shown in Figure 3.
3.1. 2 Matrix effect
Three replicate analyses of samples (10.0, 100.0 and 400.0
nglmL for salidroside) in plasma and in methanol were an-
alyzed respectively. Area ratios were between 90% and
110%, showing that matrix effects could be ignored.
3.1.3 Linearity and LLOQ
The representative regression equation was y = 1.01 X 10- 3 x
+ 2.26 X 10- 2 over the range of 5 - 500 nglmL with a cor-
relation coefficient of 0.9981. The LLOQ in plasma was
5 nglmL with the RSO and RE within ± 20%.
3.1.4 Precision and accuracy
The intra-day and inter-day preciSion and accuracy are
presented in Table 1. The precision and accuracy of the de-
veloped method conformed to the criteria for the analysis of
biological samples according to the guidance of FDA,
where the RSO determined at each concentration level is
required not to exceed ± 15% and RE within ± 15% of the
actual value.
3.1.5 Extraction recovery and stability
The recoveries of salidroside at three concentration levels
(l0, 100 and 400 nglmL) were 71.4%, 69.5% and
68.1 %, respectively, and the absolute recovery of IS was
78.5%. The extraction efficiency was stable, indicating
that the sample preparations were consistent, precise, and
reproducible at different concentration levels.
The stability results are shown in Table 2, which indica-
ted that salidroside had no significant degradation under the
conditions previously described.
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Figure 3 SIM chromatograms of a blank rat plasma (a), a blank rat plasma spiked with salidroside (400 nglmL) and IS (b),
and a rat plasma sample 30 min after oral administration of Enhi Wan suspension (c). 1, salidroside; 2, IS.
Thble 1 Precision and accuracy of salidroside in rat plasma
Spiked concentration
Inter-day precision (n - 5) Intra-day precision (n =15)
Measured concentration Measured concentration(nglmL) (mean ± SD, nglmL) RE(%) RSD (%) (mean±SD, nglmL) RE (%) RSD (%)
10 10.14±0.79 1.0 8.0 1O.14±0.75 1.0 8.0
100 98.50±5.30 -1.5 5.4 98.50± 5.30 -1.5 5.4
400 392.70 ± 14.20 -1.9 3.7 392.70 ± 55.50 -1.9 14.2
Thble 2 Stability of salidroside in rat plasma
Spiked concentration Short- term stability Freeze and thaw stability Post-preparative stability Stability for 15 d(24 h at room temperature) at - 20'C(nglmL)
Mean±SD RSD(%) Mean±SD RSD(%) Mean±SD RSD(%) Mean±SD RSD(%)
10 1O.8±0.5 4.1 1O.3±0.9 8.7 9.7±0.6 5.5 10.9±0.3 2.2
100 97.8±2.6 2.7 109.6±6.0 5.4 98.0±2.9 2.9 110.3±2.9 2.6
400 378.0± 8.3 2.2 409.l±8.1 2.0 375.l± 11. 7 3.1 435.3± 31.8 7.3
3. 2 Application in pharmacokinetic studies
The developed and validated LC-MS method was successfully
used to monitor the plasma concentrations of salidroside in
rats after oral administration of suspensions of Erzhi Wan
and Ligustri lucidi at a dose of 2.4 g (expressed as the
weight of Ligustri lucidi in water, containing 6. a mg of
salidroside) per kg body weight. The mean plasma concen-
tration-time profile is illustrated in Figure 4. The pharma-
cokinetic parameters are listed in Table 3.
In this paper, the pharmacokinetic parameters of salidro-
side were, to a certain degree, in accordance with previous
reports [10-13]. Meantime, we found that the pharmacoki-
netic parameters of salidroside after oral administration of
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suspension of Erzhi Wan were different from those after
oral administration of suspension of Fructus Ligustri lucidi.
Thble 3 The pharmacokinetic parameters of salidroside in rat plasma
after oral administration of Erzhi Wan and Fructus ligustri lucidi (at
a dose containing salidroside 6.0 mg/kg) (n = 6, mean ± SD)
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4 Conclusion
A rapid and reliable LC- MS method has been developed for
the determination of salidroside in rat plasma after oral ad-
ministration of Erzhi Wan and Fructus Ligustri lucidi. The
method is simple and ensures accurate, specific and precise
determination of salidroside in rat plasma. This is the first
report of a pharmacokinetic study of salidroside after ad-
ministration of Erzhi Wan and Fructus Ligustri lucidi. The
pharmacokinetic results may be useful for further studies of
the clinical applications of Erzhi Wan and Fructus Ligustri
lucidi.
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Figure 4 Mean plasma concentrations vs. time profile in six rats af-
ter oral administration of Erzhi Wan (.6.) and Fructus Ligustri lucidi
(0) (at a dose containing salidroside 6.0 mg/kg) (n =6).
It was demonstrated that the absorption of salidroside
after oral administration of suspension of Erzhi Wan was
slower than that of Fructus Ligustri lucidi, with their T max
O. 63 and O. 54 h, respectively. The t 1l2 value after
administration of Erzhi Wan was 1. 02 h, while that after
administration of Fructus Ligustri lucidi was 0.75 h.
AUCo., of salidroside after .administration of Erzhi Wan
was much higher than that after administration of Fructus
Ligustri lucidi, while its Cmax was significantly lower (p<
0.05). These differences could be due to the following cau-
ses: (l) other constituents in Erzhi Wan, such as the sapo-
nins and wedelolactone from Herba Ediptae, facilitated the
dissolution of salidroside from Fructus Ligustri lucidi; (2)
some ingredients in Erzhi Wan affected the absorption and
metabolism of salidroside, thus increasing its bioavailabili-
ty; (3) there are some other kinds of synergetic effects.
